Status:
UNKNOWN
Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
School of Pharmaceutical Sciences, Peking University, Beijing, China
Department of Medicine, Queen's University, Kingston, Ontario, Canada
Conditions:
Critically Ill
Coronavirus Infections
Eligibility:
All Genders
18+ years
Brief Summary
There was an interaction between mortality, nutritional intake and the Nutrition Risk in Critically ill (NUTRIC) score suggesting that those with higher NUTRIC scores benefited the most from increasin...
Detailed Description
Heyland et al. previously proposed a novel scoring tool, the Nutrition Risk in Critically ill (NUTRIC) score, which is the first nutritional risk assessment tool developed and validated specifically f...
Eligibility Criteria
Inclusion
- Admitted to intensive care unit (ICU), Peking University Third Hospital since Feb 2020
- Adult (aged over 18 years)
- Anticipate a length of ICU stay (LOS) of more than 48 hours
- Diagnosed as 2019 coronavirus disease (COVID-19)
- With food intake difficulties (can't intake food by oneself)
Exclusion
- aged under 18 years
- Actual ICU LOS of less than 48 hours
- Using medications of IL-6 or IL-6R
- Overdose
- Written informed consent not obtained in the prospective cohort
Key Trial Info
Start Date :
February 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04274322
Start Date
February 19 2020
End Date
July 1 2020
Last Update
April 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China